Publikace
- Trial watch: Peptide-based vaccines in anticancer therapy2018 | 2. lékařská fakulta
- Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis2016 | 2. lékařská fakulta
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy2016 | 2. lékařská fakulta
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | 2. lékařská fakulta
- Type I interferon and cancer2024 | 2. lékařská fakulta
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | 2. lékařská fakulta
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | 1. lékařská fakulta, 2. lékařská fakulta, Ústřední knihovna, 3. lékařská fakulta, Lékařská fakulta v Plzni
Loading network view...